Pharvaris N.V.PHVSNASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank88
3Y CAGR+22.3%
Year-over-Year Change
Year-over-year operating income growth rate
3Y CAGR
+22.3%/yr
Quarterly compound
Percentile
P88
Within normal range
vs 3Y Ago
1.8x
Solid growth
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | 1.76% |
| Q2 2025 | -195.70% |
| Q1 2025 | 187.71% |
| Q4 2024 | -26.90% |
| Q3 2024 | -10.24% |
| Q2 2024 | -21.44% |
| Q1 2024 | 3.14% |
| Q4 2023 | -11.56% |
| Q3 2023 | -7.21% |
| Q2 2023 | -8.07% |
| Q1 2023 | 5.93% |
| Q4 2022 | -6.67% |
| Q3 2022 | 0.96% |
| Q2 2022 | -17.42% |
| Q1 2022 | -19.33% |
| Q4 2021 | -21.83% |
| Q3 2021 | -4.75% |
| Q2 2021 | -7.45% |
| Q2 2021 | -21.33% |
| Q4 2020 | -55.60% |
| Q3 2020 | -9.57% |
| Q2 2020 | -76.40% |
| Q1 2020 | 14.91% |
| Q4 2019 | -90.48% |
| Q3 2019 | 0.00% |
| Q2 2019 | 0.00% |
| Q1 2019 | -85.70% |
| Q4 2018 | 0.00% |
| Q3 2018 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |
| Q4 2017 | 0.00% |
| Q3 2017 | 0.00% |
| Q2 2017 | 0.00% |
| Q1 2017 | 0.00% |